hydralazine has been researched along with Coronary Artery Disease in 2 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Heart failure affects more than 6 million people in the United States and incurs a heavy toll in morbidity, mortality, and health care costs." | 2.58 | Heart Failure. ( Wu, A, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, A | 1 |
| Hof, RP | 1 |
| Hof, A | 1 |
| Takiguchi, Y | 1 |
1 review available for hydralazine and Coronary Artery Disease
| Article | Year |
|---|---|
Heart Failure.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibit | 2018 |
1 other study available for hydralazine and Coronary Artery Disease
| Article | Year |
|---|---|
Comparative hemodynamic studies of isradipine and dihydralazine in atherosclerotic and normal rabbits.
Topics: Animals; Arteriosclerosis; Calcium Channel Blockers; Coronary Artery Disease; Dihydralazine; Electro | 1990 |